Windlas Biotech - Quaterly Results

12 May 2022 Evaluate
The company witnessed a 14.35% growth in the revenue at Rs. 1221.31 millions for the quarter ended March 2022 as compared to Rs. 1068.09 millions during the year-ago period.The company almost doubled its revenue to Rs. 152.33 millions  from Rs. 58.91 millions in the quarter ended March 2022.OP of the company witnessed a marginal growth to 172.90 millions from 119.02 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1221.31 1068.09 14.35 4659.30 4276.02 8.96 4659.30 4276.02 8.96
Other Income 30.05 7.93 278.94 67.06 30.94 116.74 67.06 30.94 116.74
PBIDT 172.90 119.02 45.27 596.01 577.86 3.14 596.01 577.86 3.14
Interest 2.88 3.24 -11.11 14.17 12.90 9.84 14.17 12.90 9.84
PBDT 170.02 115.78 46.85 581.84 241.45 140.98 581.84 241.45 140.98
Depreciation 29.02 33.58 -13.58 121.47 129.65 -6.31 121.47 129.65 -6.31
PBT 141.00 82.20 71.53 460.37 111.80 311.78 460.37 111.80 311.78
TAX -11.33 23.29 -148.65 74.76 61.70 21.17 74.76 61.70 21.17
Deferred Tax -28.50 -1.80 1483.33 -26.57 13.28 -300.08 -26.57 13.28 -300.08
PAT 152.33 58.91 158.58 385.61 50.10 669.68 385.61 50.10 669.68
Equity 108.97 64.11 69.97 108.97 64.11 69.97 108.97 64.11 69.97
PBIDTM(%) 14.16 11.14 27.04 12.79 13.51 -5.34 12.79 13.51 -5.34

Windlas Biotech Share Price

798.95 -11.00 (-1.36%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×